Back to Search
Start Over
Loganin prevents chronic constriction injury-provoked neuropathic pain by reducing TNF-α/IL-1β-mediated NF-κB activation and Schwann cell demyelination.
- Source :
-
Phytomedicine : international journal of phytotherapy and phytopharmacology [Phytomedicine] 2020 Feb; Vol. 67, pp. 153166. Date of Electronic Publication: 2019 Dec 30. - Publication Year :
- 2020
-
Abstract
- Background: Peripheral nerve injury can produce chronic and ultimately neuropathic pain. The chronic constriction injury (CCI) model has provided a deeper understanding of nociception and chronic pain. Loganin is a well-known herbal medicine with glucose-lowering action and neuroprotective activity.<br />Purpose: This study investigated the molecular mechanisms by which loganin reduced CCI-induced neuropathic pain.<br />Methods: Sprague-Dawley rats were randomly divided into four groups: sham, sham+loganin, CCI and CCI+loganin. Loganin (1 or 5 mg/kg/day) was injected intraperitoneally once daily for 14 days, starting the day after CCI. For behavioral testing, mechanical and thermal responses were assessed before surgery and on d1, d3, d7 and d14 after surgery. Sciatic nerves (SNs) were collected to measure proinflammatory cytokines. Proximal and distal SNs were collected separately for Western blotting and immunofluorescence studies.<br />Results: Thermal hyperalgesia and mechanical allodynia were reduced in the loganin-treated group as compared to the CCI group. Loganin (5 mg/kg/day) prevented CCI from inducing proinflammatory cytokines (TNF-α, IL-1β), inflammatory proteins (TNF-α, IL-1β, pNFκB, pIκB/IκB, iNOS) and receptor (TNFR1, IL-1R), adaptor protein (TRAF2) of TNF-α, and Schwann cell demyelination and axonal damage. Loganin also blocked IκB phosphorylation (p-IκB). Double immunofluorescent staining further demonstrated that pNFκB/pIκB protein was reduced by loganin in Schwann cells on d7 after CCI. In the distal stumps of injured SN, Schwann cell demyelination was correlated with pain behaviors in CCI rats.<br />Conclusion: Our findings indicate that loganin improves CCI-induced neuroinflammation and pain behavior by downregulating TNF-α/IL-1β-dependent NF-κB activation.<br />Competing Interests: Declaration of Competing Interest The authors declare no competing interest.<br /> (Copyright © 2019 Elsevier GmbH. All rights reserved.)
- Subjects :
- Animals
Chronic Pain drug therapy
Chronic Pain metabolism
Chronic Pain pathology
Constriction
Cytokines metabolism
Hyperalgesia drug therapy
Hyperalgesia metabolism
Hyperalgesia pathology
Interleukin-1beta metabolism
Male
Neuralgia metabolism
Neuralgia pathology
Rats, Sprague-Dawley
Schwann Cells metabolism
Schwann Cells pathology
Sciatic Nerve drug effects
Sciatic Nerve metabolism
Tumor Necrosis Factor-alpha metabolism
Analgesics, Non-Narcotic pharmacology
Iridoids pharmacology
NF-kappa B metabolism
Neuralgia drug therapy
Schwann Cells drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1618-095X
- Volume :
- 67
- Database :
- MEDLINE
- Journal :
- Phytomedicine : international journal of phytotherapy and phytopharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 31955133
- Full Text :
- https://doi.org/10.1016/j.phymed.2019.153166